Drug dosing in cancer patients with decreased kidney function: A practical approach
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F21%3A10424131" target="_blank" >RIV/00216208:11110/21:10424131 - isvavai.cz</a>
Alternative codes found
RIV/00064165:_____/21:10424131
Result on the web
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=ioSYcYfHOk" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=ioSYcYfHOk</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.ctrv.2020.102139" target="_blank" >10.1016/j.ctrv.2020.102139</a>
Alternative languages
Result language
angličtina
Original language name
Drug dosing in cancer patients with decreased kidney function: A practical approach
Original language description
Correct drug dosing of anticancer agents is essential to obtain optimal outcomes. Overdosing will result in increased toxicity, treatment interruption and possible cessation of anticancer treatment. Underdosing may result in suboptimal anti-cancer effects and may increase the risk of cancer-related mortality. As it is practical nor feasible to perform therapeutic drug monitoring for all anti-cancer drugs, kidney function is used to guide drug dosing for those drugs whose primary mode of excretion is through the kidney. However, it is not well-established what method should be utilized to measure or estimate kidney function and the choice of method does influence treatment decisions regarding eligibility for anti-cancer drugs and their dose. In this review, we will provide an overview regarding the importance of drug dosing, the preferred method to determine kidney function and a practical approach to drug dosing of anticancer drugs.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30217 - Urology and nephrology
Result continuities
Project
—
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2021
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Cancer Treatment Reviews
ISSN
0305-7372
e-ISSN
—
Volume of the periodical
93
Issue of the periodical within the volume
February
Country of publishing house
GB - UNITED KINGDOM
Number of pages
8
Pages from-to
102139
UT code for WoS article
000618657200003
EID of the result in the Scopus database
2-s2.0-85098724925